Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Unrelated Male Donors Versus Sibling Parous Female Donors: Impact on Transplant-Related Outcomes

Anita J Kumar, MDMS, Soyoung Kim, PhD, Michael Hemmer, MS, Mukta Arora, MD, Steve Spellman, MBS, Joseph A. Pidala, MD, Daniel Couriel, MD MS, Amin M. Alousi, MD, Alison W Loren, MD MS

Blood (2016) 128 (22): 70.

https://doi.org/10.1182/blood.V128.22.70.70

Published: 2016

Journal Articles

Influence of Age on Risk for Acute and Chronic Graft Versus Host Disease in Children Receiving HLA Identical Sibling Bone Marrow Transplantation

Muna Qayed, MD MSc, John Horan, MD MPH, Stephen R. Spellman, MBS, Mukta Arora, MD, Tao Wang, PhD, Michael Hemmer, MS, Joseph A Pidala, MD, PhD, Daniel Couriel, MD MS, Amin M. Alousi, MD

Blood (2016) 128 (22): 2228.

https://doi.org/10.1182/blood.V128.22.2228.2228

Published: 2016

Journal Articles

Plasma ST2 Concentrations Predict Development of Acute Gvhd and Non-Relapse Mortality

Mark T. Vander Lugt, M.D., Thomas M. Braun, Ph.D., Samir Hanash, M.D., Ph.D., James L.M. Ferrara, MD, DSc, Jerome Ritz, MD, Vincent T. Ho, MD, Joseph H. Antin, MD, Qing Zhang, Alice Chin, Aurelie Gomez, MD, Andrew C. Harris, M.D., John E. Levine, M.D., M.S., Sung W. Choi, M.D., Daniel Couriel, MD, Pavan Reddy, M.D., Sophie Paczesny, M.D., Ph.D

Blood (2012) 120 (21): 466.

https://doi.org/10.1182/blood.V120.21.466.466

Published: 2012

Journal Articles

Plasma Concentration of ST2, the IL33 Receptor, At Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

Mark T. Vander Lugt, M.D., Thomas Braun, PhD, James L.M. Ferrara, MD, DSc, Samir Hanash, M.D., Ph.D., John E. Levine, MD, MS, Chee-Hong Wang, Qing Zhang, Alice Chin, Andrew C. Harris, M.D., Sung W.J. Choi, M.D., Daniel Couriel, MD, Pavan Reddy, M.D., Sophie Paczesny, MD, PhD

Blood (2011) 118 (21): 152.

https://doi.org/10.1182/blood.V118.21.152.152

Published: 2011

Journal Articles

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)

Blood (2011) 118 (21): 631.

https://doi.org/10.1182/blood.V118.21.631.631

Published: 2011

Journal Articles

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Blood (2010) 116 (21): 675.

https://doi.org/10.1182/blood.V116.21.675.675

Published: 2010

Journal Articles

Non-Myeloablative Allogeneic Stem Cell Transplantation (NMT) Overcomes the Adverse Effects of Treatment Resistance and High Beta-2-Microglobulin in Patients with Mantle Cell Lymphoma (MCL): An Analysis of 123 Transplantations at the MD Anderson Cancer Center.

Constantine S. Tam, MBBS, Celina Ledesma, BS, Martin Korbling, MD, Luis E. Fayad, MD, Michael Wang, MD, Amin Alousi, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Gabriela Rondon, MD, Sergio A. Giralt, MD, Paolo Anderlini, MD, Uday Popat, MD, Daniel Couriel, MD, Barbara Pro, MD, Barry Samuels, MD, Frederick Hagemeister, MD, Richard E. Champlin, MD, Issa F. Khouri, MD

Blood (2007) 110 (11): 484.

https://doi.org/10.1182/blood.V110.11.484.484

Published: 2007

Journal Articles

Nonmyeloablative Allogeneic Transplantation (NMT) for Relapsed Follicular Lymphoma (FL): Continuous Complete Remission with Longer Follow-Up.

Issa F. Khouri, MD, Rima M. Saliba, PhD, Martin Korbling, MD, Chitra Hosing, MD, Luis Fayad, MD, Ming S. Lee, MD, Felipe Samaniego, MD, Barry I. Samuels, MD, Daniel Couriel, MD, Fredrick Hagemeister, MD, Peter McLaughlin, MD, Richard E. Champlin, MD

Blood (2007) 110 (11): 485.

https://doi.org/10.1182/blood.V110.11.485.485

Published: 2007

Journal Articles

Graft-Versus-Host Disease (GVHD) in Cord Blood Transplantation (CBT): Risk Factors, Clinical Manifestations and Outcomes.

Daniel Couriel, MD, Poliana Patah, MD, Rima Saliba, PhD, Lawrence Cooper, MD, Laura Worth, MD, Dimitrios Petropoulos, MD, Leandro Depadua, MD, Weiqing Zhang, Sergio Giralt, MD, Richard Champlin, MD, Elizabeth J. Shpall, MD, Marcos de Lima, MD

Blood (2007) 110 (11): 2977.

https://doi.org/10.1182/blood.V110.11.2977.2977

Published: 2007

Journal Articles

Long-Term Follow-Up of Allogeneic Stem Cell Transplantation (SCT) with Reduced Intensity Conditioning (RIC) for Patients (pts) with Chronic Myeloid Leukemia (CML).

Partow Kebriaei, MD, Michelle Detry, PhD, Antonio Carrasco-Yalan, MD, Athanasios Anagnostopoulos, MD, Daniel Couriel, MD, Issa Khouri, MD, Paolo Anderlini, MD, Chitra Hosing, MD, Amin Alousi, MD, Sergio Giralt, MD, Richard Champlin, MD, Marcos de Lima, MD

Blood (2006) 108 (11): 2898.

https://doi.org/10.1182/blood.V108.11.2898.2898

Published: 2006

Journal Articles

High-Dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Transplantation (AHCT) for Non-Hodgkin’s Lymphoma (NHL) in Patients over 65 Years of Age.

Chitra Hosing, MD, Rima M. Saliba, PHD, Grace-Julia Okoroji, Uday Popat, MD, Daniel Couriel, MD, Partow Kebriaei, MD, Tanveer Ali, Marcos De Lima, MD, Muzaffar Qazilbash, MD, Paolo Anderlini, MD, Sergio Giralt, MD, Richard E. Champlin, MD, Issa Khouri, MD

Blood (2006) 108 (11): 3059.

https://doi.org/10.1182/blood.V108.11.3059.3059

Published: 2006

Journal Articles

"Prophylactic" Platelet (PLT) Transfusions in the Setting of Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): Similar Clinical Efficacy of Single Donor (SDP) and Random Donor Pooled (RDP) Platelet Products.

Poliana A. Patah, MD, Emel Gurkan, MD, Rima Saliba, PhD, Marcos de Lima, MD, Gabriela Rondon, MD, Carlos A. Ramos, MD, Daniel Couriel, MD, Jonas A. de Souza, MD, Richard Champlin, MD, Benjamin Lichtiger, MD

Blood (2006) 108 (11): 597.

https://doi.org/10.1182/blood.V108.11.597.597

Published: 2006

Journal Articles

Natural History of AML / MDS Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Reduced Intensity (RIC) Preparative Regimens.

Betul Oran, MD, Sergio Giralt, MD, Munir Shahjahan, MD, Athanasios Anagnostopoulos, MD, Daniel Couriel, MD, Partow Kebriaei, MD, Chitra Hosing, MD, Shubhra Ghosh, MD, Ernesto de Meis, MD, Michele Donato, MD, Touch Ativivas, MD, Antonio Carrasco-Yalan, MD, Richard Champlin, MD, Marcos de Lima, MD

Blood (2005) 106 (11): 2019.

https://doi.org/10.1182/blood.V106.11.2019.2019

Published: 2005

Journal Articles

Secondary Malignancy after Allogeneic Stem Cell Transplantation: Incidence and Risk Factors.

Chitra Hosing, MD, Rima M. Saliba, PhD, Marcos De Lima, MD, Sergio Giralt, MD, Shubhra Ghosh, MD, Yvonne Hsu, Paolo Anderlini, MD, Sharon R. Hymes, MD, Borje Andersson, MD, Issa F. Khouri, MD, Richard Champlin, MD, Daniel Couriel, MD

Blood (2005) 106 (11): 1123.

https://doi.org/10.1182/blood.V106.11.1123.1123

Published: 2005

Journal Articles

Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: A New Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Muzaffar H. Qazilbash, MD, Marilyn S. Davis, Aleman Ana, Linda Roden, Floralyn Libunao, Peter F. Thall, PhD, Xuemei Wang, Daniel Couriel, MD, Marcos De Lima, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Donna Weber, MD, Michael Wang, MD, Roy B. Jones, MD, Ph.D, Steven G. Matthes, Richard E. Champlin, MD, Sergio A. Giralt, MD

Blood (2005) 106 (11): 1159.

https://doi.org/10.1182/blood.V106.11.1159.1159

Published: 2005

Journal Articles

Steroid Complications in Patients with Acute Graft Versus Host Disease.

Oran Betul, MD, Hun Lee, MS, Marcos de Lima, MD, Daniel Couriel, MD, Sergio Giralt, MD, Rima Saliba, Ph.D

Blood (2005) 106 (11): 5338.

https://doi.org/10.1182/blood.V106.11.5338.5338

Published: 2005

Journal Articles

Second Autologous or Allogeneic Transplantation after the Failure of First Autograft in Multiple Myeloma.

Muzaffar H. Qazilbash, MD, Rima Saliba, PhD, Marcos de Lima, MD, Daniel Couriel, MD, Chitra Hosing, MD, Ana Aleman, X Lei, Richard E. Champlin, MD, Sergio A. Giralt, MD

Blood (2004) 104 (11): 3329.

https://doi.org/10.1182/blood.V104.11.3329.3329

Published: 2004

Journal Articles

Vaccination with the PR1 Leukemia-Associated Antigen Can Induce Complete Remission in Patients with Myeloid Leukemia.

Muzaffar H. Qazilbash, MD, Eric Wieder, PhD, Rosa Rios, Sijie Lu, Shreya Kant, Sergio Giralt, MD, Elihu H. Estey, MD, Peter Thall, Marcos de Lima, MD, Daniel Couriel, MD, Richard E. Champlin, MD, Krishna Komanduri, MD, Jeffrey J. Molldrem, MD

Blood (2004) 104 (11): 259.

https://doi.org/10.1182/blood.V104.11.259.259

Published: 2004

NARROW

Unrelated Male Donors Versus Sibling Parous Female Donors: Impact on Transplant-Related Outcomes

Influence of Age on Risk for Acute and Chronic Graft Versus Host Disease in Children Receiving HLA Identical Sibling Bone Marrow Transplantation

Plasma ST2 Concentrations Predict Development of Acute Gvhd and Non-Relapse Mortality

Plasma Concentration of ST2, the IL33 Receptor, At Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Non-Myeloablative Allogeneic Stem Cell Transplantation (NMT) Overcomes the Adverse Effects of Treatment Resistance and High Beta-2-Microglobulin in Patients with Mantle Cell Lymphoma (MCL): An Analysis of 123 Transplantations at the MD Anderson Cancer Center.

Nonmyeloablative Allogeneic Transplantation (NMT) for Relapsed Follicular Lymphoma (FL): Continuous Complete Remission with Longer Follow-Up.

Graft-Versus-Host Disease (GVHD) in Cord Blood Transplantation (CBT): Risk Factors, Clinical Manifestations and Outcomes.

Long-Term Follow-Up of Allogeneic Stem Cell Transplantation (SCT) with Reduced Intensity Conditioning (RIC) for Patients (pts) with Chronic Myeloid Leukemia (CML).

High-Dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Transplantation (AHCT) for Non-Hodgkin’s Lymphoma (NHL) in Patients over 65 Years of Age.

"Prophylactic" Platelet (PLT) Transfusions in the Setting of Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): Similar Clinical Efficacy of Single Donor (SDP) and Random Donor Pooled (RDP) Platelet Products.

Natural History of AML / MDS Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Reduced Intensity (RIC) Preparative Regimens.

Secondary Malignancy after Allogeneic Stem Cell Transplantation: Incidence and Risk Factors.

Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: A New Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Steroid Complications in Patients with Acute Graft Versus Host Disease.

Second Autologous or Allogeneic Transplantation after the Failure of First Autograft in Multiple Myeloma.

Vaccination with the PR1 Leukemia-Associated Antigen Can Induce Complete Remission in Patients with Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only